Polivy 140 MG vials
Ended Awarded
- Contract number
- SPE2DB25FZ1PF
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,023
Award facts
- Contract value 100% obligated
- $11,023.03 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $11,023.03 delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Polivy 140 mg vials, with an ultimate completion date of October 17, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded through open competition. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999.999 billion ceiling value and extends through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran healthcare systems.
The pharmaceutical products will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. Polivy (polatuzumab vedotin) is a specialized oncology medication used in cancer treatment, reflecting AmerisourceBergen's extensive portfolio of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medical commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide.
Quick answers
Who was awarded contract SPE2DB25FZ1PF?
SPE2DB25FZ1PF was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 25, 2025.
How much is contract SPE2DB25FZ1PF worth?
The government has obligated $11,023 on SPE2DB25FZ1PF.
Is contract SPE2DB25FZ1PF an order under another contract?
Yes. SPE2DB25FZ1PF is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB25FZ1PF competed?
The extent of competition for SPE2DB25FZ1PF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award